about
Imaging biomarkers in primary brain tumours.PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Nuclear medicine procedures in lung cancer.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidenceFDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.Surgical sentinel lymph node biopsy in early breast cancer. Could it be avoided by performing a preoperative staging procedure? A pilot study.FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.Isotopic biomarker discovery and application in translational medicine.Surgical procedures in the DANTE trial, a randomized study of lung cancer early detection with spiral computed tomography: comparative analysis in the screening and control arm.Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.Somatostatin receptor SPECT.Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review.Salvage therapy of small volume prostate cancer nodal failures: a review of the literature.Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.Standardization and quantification in PET/CT imaging: tracers beyond FDG.Applications of PET imaging with radiolabelled choline (11C/18F-choline).Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resources.PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014.A risk management approach for imaging biomarker-driven clinical trials in oncology.[(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors.Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper.Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global Standardization.Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology.Isolated pelvic perfusion for the treatment of unresectable primary or recurrent rectal cancer.Myocardial involvement in systemic sclerosis.A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET).Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography.Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors.High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.Metastatic gastric cancer presenting with shoulder-hand syndrome: a case report.Feasibility of carbidopa premedication in pediatric patients: a pilot study.Clinical use of PET-CT data for radiotherapy planning: what are we looking for?131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings.Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.
P50
Q30880129-466E38E0-92DB-4157-B3E5-186CCA4EA24BQ31003607-20D62703-C8EF-45EB-9F29-DEEEF64CE3D3Q33669762-76A61685-26BF-42DE-9E4C-8BABD0915343Q33818999-91212A7C-EEEE-4F6E-A14F-6CAF81C6A958Q35043725-EE4298A4-4408-40E4-B819-D71A029C2162Q36094726-56197BD3-5125-4D5E-9685-9D3F14B73863Q36467722-02A978FF-8A77-47B2-B544-5F623B70A272Q36577105-F5EA27AD-7B8C-406A-9BB1-7C6BE62479BFQ37469186-D104D792-1FC5-4CA9-87D9-057494E0556BQ37663677-EEAC31E9-C8B3-4F9D-A9B6-6887E43C1D79Q37823153-653BD28A-F685-4C73-B4DF-0C974058D4DFQ37864159-3C787D02-4E5A-471C-AFFF-5000F3F6CE05Q37990407-DD3E2DE8-60F9-4A0A-9351-07431F73859CQ38129578-5DA3F9FC-A175-42A0-87A0-5AEA192BFB3AQ38169396-2BD3D080-6171-4F0B-8E73-298F995D25FBQ38230176-A725547B-DE03-4F89-8574-2596DB17AC2BQ38230229-2AAB1AF6-8D2B-4A8B-85F6-1154743890DCQ38353970-77511BF6-A168-479B-BB48-317A4C7D3B3FQ38373761-0A4801AD-5131-460A-B3FF-75FEF2617FFDQ38376222-64F4FFDC-B1C3-4A1E-A57B-A9805154E6B0Q38419113-E2F641A7-CABA-474F-84F6-99646457E640Q38672078-15FF32D1-5AA2-4F5C-9D1C-BAF6B7D82D0AQ38677216-EA678733-F2E4-4482-B94C-ACBECA427EB4Q38686171-7F9930C0-2AC3-490D-AE46-D661183190D3Q38795208-180C40C9-22FD-4540-91BA-FBCAF903C4DDQ39007387-E3EBDC67-FDA5-4DB4-8BA9-7380825F6716Q39197536-C732AD64-F885-42DC-BC43-52CA2F0EBB82Q39462236-CE504343-64E6-49D5-8658-19E219E95EACQ39847659-E5690F03-A494-42F9-81B6-416511F43A1EQ40429600-F4ED7085-3779-419C-B304-653F67ED0398Q40906528-77C77D9A-9C41-4694-87E7-5950F8769417Q41421285-7D90D068-32C9-4662-966D-5482F5CEEBF4Q41525624-D2D3FC66-DBC2-4972-93A0-01EB1E89D0FFQ41914577-BFCB4DCB-9FCB-4CB5-8CE0-4F4FEB490CDAQ42513702-8CB74817-AA89-4FD7-9482-9FD82C58A23DQ42930852-88B72C2F-A692-4666-A340-7DF7EDD64EC9Q42965034-95E548B4-AD03-46BD-BD13-525EBB9C2E84Q42993036-F4AE8688-E66B-4D36-9C9C-F297792FB571Q43098306-D596D959-71A5-42DF-B9D3-09AB7BCE7C3BQ43218026-E7E0DACC-8FED-4FB8-BF53-7F05E160A598
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Arturo Chiti
@ast
Arturo Chiti
@en
Arturo Chiti
@es
Arturo Chiti
@nl
Arturo Chiti
@sl
type
label
Arturo Chiti
@ast
Arturo Chiti
@en
Arturo Chiti
@es
Arturo Chiti
@nl
Arturo Chiti
@sl
prefLabel
Arturo Chiti
@ast
Arturo Chiti
@en
Arturo Chiti
@es
Arturo Chiti
@nl
Arturo Chiti
@sl
P108
P1053
K-6524-2016
P106
P1153
22955689900
P21
P214
89145304925978610515
P31
P3829
P496
0000-0002-5806-1856
P734
P735
P7859
viaf-89145304925978610515